(R)-1-Methyl-1,2,3,4-tetrahydro-isoquinoline hydrochloride, 95+%, 100mg

5-Phenylcyclohexane-1,3-dione, 98.0%, 1g

2-Amino-4-bromo-6-methylbenzothiazole, 95.0%, 250mg

5-AMINO-2-(METHYLTHIO)PYRIMIDINE, 97.0%, 5g

H-Tyr-OMe, 98.00%, 5g

�-D-Galactose pentaacetate, 98.0%, 25g

5-Methylpyrimidine-2-carbonitrile, 95.0%, 1g

2-Chloro-5-fluoroisonicotinaldehyde, 95.0%, 250mg

N-(4-Methylphenyl)Sulfonylacetamide, 97%, 1g

((4-(tert-butyl)phenyl)sulfonyl)proline, 95.0%, 500mg

cis-11-Hexadecenal>95.0%(GC)1g

Narrow mouth bottle aluminium with UN approval, 125 ml, 1 Piece

n-(2-Aminoethyl)-3-({2-[(2-aminoethyl)carbamoyl]ethyl}({2-[bis({2-[(2-aminoethyl)carbamoyl]ethyl})amino]ethyl})amino)propanamide, 98%, 1g